Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
Top

12-08-2016 | Hypoglycemia | Case report | Article

17. Hypoglycaemia Case Study

Publisher: Springer London

Login to get access

Abstract

The case of a 38-year-old woman with Addison’s disease, diabetes and recurrent severe hypoglycaemia is described. After some initial diagnostic uncertainty, it was confirmed that she had autoimmune diabetes. She subsequently developed recurrent episodes of severe hypoglycaemia with few or no warning symptoms. The options for managing this scenario are discussed, including increased blood glucose monitoring, carbohydrate counting, education on insulin adjustment, insulin pump therapy and islet cell transplants.

Literature
1.
Gangji AS, Cukierman T, Gerstein HC, Goldsmith CH, Clase CM. A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other insulin secretagogues and with insulin. Diabetes Care. 2007;30:389–94.CrossRefPubMed
2.
Marbury T, Huang W, Strange P, Lebovitz H. Repaglinide versus glyburide: a one-year comparison trial. Diabetes Res Clin Pract. 1999;43(3):155–66.CrossRefPubMed
3.
Ristic S, Collober-Maugeais C, Cressier F, Tang P, Pecher E, Ristic S, Collober-Maugeais C, Cressier F, et al. Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results. Diabetes Obes Metab. 2007;9(4):506–11.CrossRefPubMed
4.
Ristic S, Collober-Maugeais C, Pecher E, Cressier F. Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone. Diabet Med. 2006;23(7):757–62.CrossRefPubMedCentralPubMed
5.
Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab. 2008;4:200–13.CrossRefPubMed
6.
Zammitt NN, Warren RE, Deary IJ, Frier BM. Delayed recovery of cognitive function following hypoglycemia in adults with type 1 diabetes. Effect of impaired awareness of hypoglycemia. Diabetes. 2008;57:732–6.CrossRefPubMed
7.
Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17:697–703.CrossRefPubMed
8.
Clarke WL, Cox DJ, Gonder-Frederick L, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995;18:517–22.CrossRefPubMed
9.
Geddes J, Wright RJ, Zammitt NN, Deary IJ, Frier BM. Evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes. Diabetes Care. 2007;30(7):1868–70.CrossRefPubMed
10.
Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med. 1991;8:217–22.CrossRefPubMed
11.
Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med. 2008;25:501–4.
12.
Mühlhauser I, Heinemann L, Fritsche E, von Lennep K, Berger M. Hypoglycemic symptoms and frequency of severe hypoglycemia in patients treated with human and animal insulin preparations. Diabetes Care. 1991;14:745–9.
13.
Orchard TJ, Maser RE, Becker DJ, Dorman JS, Drash AL. Human insulin use and hypoglycaemia: insights from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabet Med. 1991;8:469–74.CrossRefPubMed
14.
National Institute for Health and Clinical Excellence. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. NICE technology appraisal guidance 151; 2008. Ref Type: Online Source, London.
15.
National Institute for Health and Clinical Excellence. Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus. Interventional procedure guidance 257; 2008. Ref Type: Online Source, London.

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »

Image Credits